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ABSTRACT
Aging is associated with a progressive dysregulation of
immune responses. Whether these changes are solely
responsible for the observed increased mortality and
morbidity amongst the elderly is uncertain. Recent ad-
vances have highlighted the age-associated changes
that occur beyond T and B lymphocytes. Additionally,
multiple human and animal studies have identified a rela-
tionship between chronic low-grade inflammation and
geriatric syndromes, such as frailty, suggesting that the
phenomenon of “inflamm-aging” may provide a rationale
for the increased vulnerability to chronic inflammatory
diseases in older adults. In the present review, we
broadly summarize our current understanding of age-de-
pendent changes in leukocyte function and their contribu-
tion to aging-related disease processes. J. Leukoc. Biol.
87: 1001–1009; 2010.
Introduction
The immune system undergoes characteristic and multifaceted
changes with aging. These changes occur in all leukocytes and
accordingly, affect innate and adaptive immune functions. Al-
though certain specific immune responses are diminished with
aging, others are unaffected or even exacerbated. Paradoxi-
cally, a state of low-grade chronic inflammation is also com-
monly observed in the elderly. This chronic inflammatory
state, referred to as “inflamm-aging”, was first described when
it was shown that PBMCs from aged people are able to pro-
duce higher amounts of proinflammatory cytokines than those
from young subjects [1], an observation that on the surface,
appears to defy the dominant hypothesis at the time—that el-
derly individuals are immunodepressed. Inflamm-aging results
from exposure to continuous antigenic stress, ultimately lead-
ing to the up-regulation of cellular and molecular processes
[2] and favoring susceptibility to age-related diseases. In the
following sections, we will highlight the changes in leukocyte
function during aging and their implications for the pathogen-
esis of age-associated diseases. It should be emphasized that in
many instances, the reports in the literature are inconsistent
and even contradictory. This may be attributed to the varying
sources of the cells (such as humans or mice), culture condi-
tions, and methodological approaches used in the studies. In
the case of leukocytes that migrate to peripheral tissues, the
effect of the local environment studied in vitro and the effect
of the aged microenvironment in vivo may also account for
discrepancies in the results. Similarly, comparing results from
different human studies is difficult because of varying criteria




Neutrophils are key components of the inflammatory re-
sponse that shape immune responses and participate in the
breakdown and repair of tissue [3]. A growing body of data
has implicated neutrophils in immunosurveillance and me-
tastasis, but how aging-dependent changes in neutrophil
function contribute to diseases in the elderly is incom-
pletely understood. A recent review by Fortin et al. [4]
highlights the role of neutrophils in age-related pathologies,
such as Alzheimer’s disease, atherosclerosis, cancer, and au-
toimmune diseases. Although no change in the number of
mature, circulating neutrophils has been noted with aging,
numerous functional changes have been described, but in
almost all instances, these findings have been inconsistent
(reviewed in ref. [5]). Although some investigators have ob-
served impaired chemotaxis in human neutrophils, others
failed to uncover any differences [6 –10]. This discrepancy
may be attributable to different chemotactic stimuli being
used and whether the neutrophils were primed. For exam-
ple, Fulop et al. [10] detected an age-dependent decrease
in the chemotaxis of freshly isolated human neutrophils to-
ward fMLP and GM-CSF but not LPS. Interestingly, priming
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with GM-CSF was able to enhance chemotaxis of young neu-
trophils significantly (compared with basal status without
GM-CSF exposure) but unable to exert the same effect in
old neutrophils [10]. This impairment in priming with GM-
CSF has also been linked to defects in the respiratory burst
of neutrophils [11]. Age-related changes in GM-CSF-in-
duced signaling have been highlighted in a recent review
[12]. Whether the production of ROS is altered in aged
neutrophils remains a controversial issue [13, 14]. Ogawa et
al. [15] recently detected an increase in spontaneous ROS
production by aged human neutrophils but no difference in
fMLP or LPS-induced ROS production. Studies by Fulop et
al. [10] indicate that the kinetics of ROS production may
be altered in aging, as superoxide anion levels from aged
human neutrophils are lower than those from young neu-
trophils at early time-points (2 min and 24 h) but higher at
later time-points (48 h). In a small study conducted in
Spain involving young and middle-aged individuals as well
as centenarians, superoxide anion concentrations in neutro-
phils were found to increase with age [16]. On the other
hand, the neutrophils of centenarians contained superoxide
anion levels that were comparable with those of young
adults. In support of data that link activity of the antioxi-
dant enzyme catalase to longevity in mice [17], the neutro-
phils of centenarians also displayed the highest catalase ac-
tivity when compared with young and middle-aged subjects
[16]. A limited number of studies have addressed age-de-
pendent changes in murine neutrophil function. A report
published by Nishio et al. [18] suggests that greater num-
bers of neutrophils are required for wound repair in old
than in young mice, perhaps as a result of reduced neutro-
phil function. Although neutrophils have been implicated
in the pathogenesis of atherosclerosis since the late 1980s,
surprisingly, their presence in atherosclerotic lesions was
only demonstrated recently in two widely used mouse mod-
els of atherosclerosis, the apolipoprotein E-deficient mouse
and the low-density lipoprotein receptor-deficient mouse
[19, 20]. Zernecke et al. [20] observed that expression of
the chemokine receptor CXCR4 is up-regulated in murine
neutrophils that have been “aged” in vitro [21–23], and its
ligand CXCL12 (SDF-1) plays a pivotal role in the recruit-
ment of neutrophils to atherosclerotic plaques. However,
although up-regulation of CXCR4 expression has been es-
tablished in human neutrophils that have been aged in cul-
ture [23], there is no published work that describes the ex-
pression of CXCR4 on neutrophils from aged individuals.
Clearly, as atherosclerosis is considered primarily to be a
disease associated with aging, further investigations aimed at
unraveling how age-dependent changes in neutrophil func-
tion contribute to the pathogenesis of atherosclerosis de-
mand our prompt attention.
Eosinophils and basophils
Eosinophils and basophils are effector cells of the innate
immune system that play a central role in the pathogenesis
of allergic inflammation and protective immunity in re-
sponse to parasitic infections with helminths. Aged mice dis-
played greater airway eosinophilia in response to OVA chal-
lenge than young mice [24]. Conversely, airway hyper-re-
sponsiveness was reduced in aged mice, suggesting that
eosinophil effector function declines with aging [24]. In
contrast, Yagi et al. [25] found that aged rats failed to accu-
mulate eosinophils in allergic inflammation of the airway.
The only human study in asthma patients by Mathur et al.
[26] indicates that airway eosinophilia is comparable in
younger and older subjects. Degranulation of peripheral
blood eosinophils in response to IL-5 (but not fMLP) was
suppressed in elderly asthmatics, whereas adhesion and che-
motaxis were unchanged. In addition, no significant differ-
ence in superoxide anion production was found between
eosinophils from younger and older subjects following stim-
ulation with PMA. However, age-dependent changes in func-
tional characteristics of airway eosinophils (which are
known to be distinct from peripheral blood eosinophils)
were not examined in this study [26].
At present, our understanding of age-dependent effects
on basophil development and in vivo function is incomplete
[27]. In humans, IgE-mediated releasability of histamine
and basophil sensitivity to anti-IgE increase with age [28].
Emerging findings that basophils can support humoral
memory responses, drive IgE-dependent dermatitis, and
shift an immune response toward Th2-dominated inflamma-
tion have resulted in a resurgence in interest in these gran-
ulocytes [29]. Furthermore, it was demonstrated recently
that basophils readily generate large quantities of Th2 cyto-
kines such as IL-4 and IL-13 in humans and mice [30].
These cytokines are central regulators in conditioning Th2-
type immune responses. Basophil-derived IL-4 has been
shown to drive the differentiation of naı̈ve murine CD4 T
cells to Th2 cells [31]. Basophils also stimulate B cells to
synthesize IgE in vitro in an IL-4- and CD40 ligand-depen-
dent manner. These newly identified functions of basophils
clearly suggest that their role in aging-dependent immune
responses and pathological processes necessitates further
investigation.
MONOCYTES/MACROPHAGES
After leaving the BM and entering the blood, monocytes
differentiate continuously into macrophages en route to pe-
ripheral tissues. Aging-associated changes in monocyte and
macrophage function have been recognized as major con-
tributors to dysregulation of the immune system in a variety
of disease processes. Recently, the hypothesis that macro-
phage populations are distinctly heterogenous, and age-de-
pendent changes in macrophage function occur in a tissue-
specific manner has gained widespread acceptance [32, 33].
Macrophages are highly plastic, and the tissue microenvi-
ronment in which they reside as well as the aging process
can modify their function continuously. Dace and Apte [32]
observed in a murine model of age-related macular degen-
eration that macrophages shift from an antiangiogenic,
proinflammatory phenotype dominant in young animals to
a proangiogenic, anti-inflammatory phenotype present in
old mice. IL-10 was identified as a key mediator of this
switch, and concentrations of this cytokine are elevated in
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macrophages from aged rodents and humans [32]. Kelly et
al. [34] reported that in mice, aging is associated with en-
hanced ocular angiogenesis following laser injury, which is
linked to increased macrophage IL-10 production.
TLRs are expressed on a variety of different cell types in-
cluding classic APCs, such as DCs, monocytes, and macro-
phages, as well as on B, epithelial, and endothelial cells
[35]. They are activated by recognizing phylogenetically
well-preserved PAMPs [35]. Recent studies indicate that sig-
naling via TLR1/2 heterodimers, as well as TLR-induced
costimulatory expression in monocytes, is reduced signifi-
cantly in the elderly [35]. These defects may contribute to
the impaired phagocytosis of infectious agents and dimin-
ished response to vaccinations that are associated with ag-
ing. Investigations of age-dependent changes in macrophage
function have yielded inconsistent findings regarding pro-
duction of the cytokines TNF- and IL-6, expression of cy-
clooxygenase-2, phagocytosis, and chemotaxis [5]. When
comparing macrophages derived from the BM of young and
old mice, Sebastián et al. [36] found recently that telomeres
shorten with age. Telomeres are tandem hexanucleotide
repeats capped by telomere DNA-binding proteins at the
ends of eukaryotic chromosomes. With each duplication of
the chromosome, a small segment of the telomere is lost,
and when the telomeres reach a critically short length, cells
lose the ability to divide, thus entering a state of replicative
senescence, a phase in which their functions and activities
change. Hence, telomere shortening during cell division
represents a molecular clock that triggers the entry of cells
into senescence [37]. In macrophages, telomere shortening
leads to decreased proliferation in response to GM-CSF but
not M-CSF as a result of decreased phosporylation of the
transcription factor STAT5a. Macrophages from old mice
were more vulnerable to oxidants and had higher concen-
trations of intracellular ROS than those from their young
counterparts [36]. Oxidation of STAT5a is required for its
phosphorylation and was reduced in macrophages of aged
mice. Interestingly, macrophages from telomerase knockout
mice displayed the same phenotype as aged macrophages,
suggesting that telomere shortening may cause enhanced
oxidative stress, reduced STAT5a oxidation, and phosphory-
lation, which ultimately, result in the impaired GM-CSF-de-
pendent macrophage proliferation [36]. For a comprehen-
sive review of aging-related phenotypic and functional
changes of circulating monocytes, the reader is referred to
a recent book chapter by Ginaldi and De Martinis [38] and
the references cited therein. Age-related effects on macro-
phage polarization and their implications for angiogenesis
have been reviewed by Dace and Apte [32].
DCS
DCs are a sparsely distributed, heterogeneous, BM-derived
population of potent APCs that can be divided into two ma-
jor categories: those present in peripheral blood (including
cDCs and pDCs) and those present in tissues/organs includ-
ing LCs in the skin, interstitial DCs in tissues, and interdigi-
tating DCs in the thymus and other lymphoid organs [39].
More than three decades after their discovery, DCs have
now emerged as key modulators of a repertoire of immune
processes, including immune surveillance, induction of im-
munological tolerance, regulation of T cell immune re-
sponses, autoimmunity, and antimicrobial immunity [40,
41]. The diverse functions of DCs depend on the heteroge-
neity of DC subsets and their functional plasticity, as well as
their location and activation or maturation status [42– 44].
In contrast to the rapidly increasing amount of knowl-
edge pertaining to DC physiology in young individuals, rela-
tively little is known about DCs in aged humans and ani-
mals. The following sections summarize the currently avail-
able studies. It is important to note that the results are often
contradictory and difficult to compare as the origin of the cells,
their culture conditions, and maturation protocols vary greatly.
Standardization of such culture procedures and more studies in
frail and healthy elderly are necessary to achieve a consensus re-
garding the effect of aging on DC-mediated immune responses.
Number
A decreased density of LCs has been described consistently
in the aged murine and human skin (recently reviewed in
refs. [45, 46]). Several studies were performed to address
the question of whether the number of human pDCs and
cDCs was reduced in old age. Using DC subset-specific cell-
surface markers and flow cytometry analysis, two recent re-
ports showed a significant age-related numerical decline of
pDCs but unchanged cDC numbers in peripheral blood
from healthy young and elderly donors [47, 48]. Interest-
ingly, Jing et al. [47] found that the preserved cDC fre-
quency with age among healthy subjects can be impacted
profoundly and negatively by declining health status in the
elderly. The reduced pDC and unaltered cDC numbers in
aged donors have been reported in at least three other
studies for each subset (refs. [49 –51] and [52–54], respec-
tively), whereas two other groups have reported no differ-
ence in the number of pDCs with aging [55, 56]. The use
of Ficoll-enriched cells versus whole blood, as well as differ-
ences in sample population, sample size, and number of
events acquired during the flow cytometry analysis may con-
tribute to the inconsistent findings with age in those stud-
ies.
With respect to ex vivo-derived DCs, we [57] and others [52,
54, 58, 59] have found no age-associated changes in the number
and morphology of cDCs generated from human blood MO-DCs
or murine BM-DCs in the presence of GM-CSF and IL-4.
Migration
The migration of mature DCs that have encountered anti-
gen in peripheral tissues to the secondary lymphoid organs,
where they can induce an immune response, is dependent
on chemokine signaling between lymphoid homing receptor
CCR7 expressed by DCs and its ligands expressed by the
microenvironment. Findings from our laboratory [60] show
that despite similar levels of expression of CCR7, aged mu-
rine BM-DCs have an impaired capacity, not only to migrate
in vitro in response to the CCR7 ligand secondary lymphoid
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tissue chemokine but also to be recruited in vivo to drain-
ing lymph nodes. This was associated with a defect in CCR7
signal transduction. Agrawal et al. [55] reported similar defec-
tive in vitro chemokine-dependent migration of human MO-DCs
using MIP-3, another CCR7 ligand, and attributed their results
to defects in the downstream signaling pathway, possibly in the
PI3K pathway. However, in another study, Pietschmann et al.
[53] found that the in vitro migration of human MO-DCs,
through an endothelial monolayer, was unimpaired. Whether the
migration of LCs is affected by the aging process also remains
controversial. Although some reports indicate reduced LC migra-
tion in response to allergen in aged mice [61] and TNF- in the
elderly [62], others demonstrate that the capacity of LCs to mi-
grate from the skin to the draining lymph nodes was not im-
paired in aged mice [63]. This suggests a selective effect of aging
on DC responsiveness to the signals involved in the migratory
process.
Phagocytosis
Although a reduction in the phagocytic capacity of DCs with
age would not only result in reduced clearance of infections
but would also contribute to age-associated loss of periph-
eral self-tolerance and chronic inflammation, data about the
effect of aging on this DC function are limited. The only
human study by Agrawal et al. [55] described decreased po-
tential for micropinocytosis of Lucifer Yellow dye, endocyto-
sis of dextran beads, and phagocytosis of apoptotic Jurkat T
cells in MO-DCs. The authors proposed that the observed,
reduced phagocytosis in aged DCs is a result of an impaired
PI3K signaling pathway via decreased phosphorylation of
AKT. Paula et al. [64] reported that phagocytosis of ne-
crotic B16F10 melanoma tumor cells was unaffected by age
in BM-DCs from C57BL/6 mice. Using the same strain of
mice, we found [60] no significant changes in the uptake of
whole OVA protein or OVA peptides by BM-DCs. Notably,
decreased expression of C-type lectin receptors, CD205 and
DC-specific/intracellular adhesion molecule type 3-grabbing
nonintegrin, in murine aged DCs has been reported by our
group [57, 60] and others [65]. However, the consequences
of this altered expression for DC-mediated phagocytosis re-
main to be ascertained.
Maturation
DC maturation is dependent on the binding of PAMPs de-
rived from bacteria, fungi, parasites, and viruses to TLRs
[66]. Although TLR expression by murine BM-DCs or
splenic DCs seems to remain unaltered with age [67], there
is some controversy regarding the responsiveness of these
cells to maturation stimuli in old age, as measured in terms
of phenotypic modification and cytokine production (re-
viewed in ref. [60]). Similarly, no consensus has been
reached yet concerning DCs from elderly individuals [45,
46]. Two recent studies have focused on the impact of ag-
ing on the ability of human pDCs to secrete type I IFN in
response to viruses. Both revealed decreased IFN- produc-
tion in response to influenza virus [47] and HSV-2 stimula-
tion [68], resulting in defective host responses to viral infec-
tions. This was associated with increased oxidative stress and
decreased TLR-7 and TLR-9 expression/signaling pathways.
Because of the importance of pDCs in antiviral responses, a
functional decline of pDCs is likely to contribute to the age-
related decrease in the Th1 response to influenza and the
impaired immune response to viral infections in the elderly.
T cell stimulatory properties and consequences for
DC-based immunotherapies
No consensus has been reached yet regarding the impact of
aging on DC capacity to induce T cell responses. Whereas
some studies [64, 69], including ours [57, 60], have re-
ported a decline in class I and/or class II antigen presenta-
tion capacity, others [52, 54, 58, 63] have described no
change or even an increase. DCs represent useful tools for
the development of novel immunotherapies, in particular,
as carriers of tumor vaccines or other immunization re-
gimes. Our group and others (recently reviewed in ref.
[60]) have investigated whether aging affects DC anti-tumor
activity and found that DC-based vaccination was under-
mined in aging as a result of poor priming of tumor anti-
gen-specific T cells as well as other DC age-related changes.
Importantly, Sharma et al. [70] showed that protective anti-
tumor immune responses in mice could be restored with
appropriate costimulation. An original study by Moretto et
al. [71] also demonstrated that aging affects the ability of
mucosal murine DCs to mount a robust T cell response
against Encephalitozoon cuniculi, an intracellular parasite. The
authors observed that old murine DCs have a defect in
IL-15 induction and that treatment of the cells with this cy-
tokine has the potential to restore their function. These
studies indicate that aged DCs can be exploited for the in-
duction of optimal immunity and consequently, lead to
more effective therapies in the elderly.
T CELLS
Increase in memory T cells and decrease in naı̈ve T
cells
Memory and naı̈ve human T cells are often distinguished based
on their expression of members of the CD45 family of surface
antigens. Thus, CD45RA antigen is expressed primarily on naı̈ve
T lymphocytes, and CD45RO is present on the cell surface of a
primed population of memory T lymphocytes. With normal ag-
ing, the slow turnover and long lifespan of naı̈ve T cells are pre-
served [72], but thymus output diminishes gradually and ulti-
mately, becomes insufficient to replace naı̈ve T cells lost from the
periphery and to maintain the breadth of the T cell repertoire
[73, 74]. Conversely, cumulative exposure to foreign pathogens
and environmental antigens promotes the accumulation of mem-
ory T cells with age [75]. Thus, elderly individuals have more
CD29 and CD45RO and less CD45RA peripheral blood CD4
and CD8 cells. The natural decline in the number of naı̈ve T
cells coupled with the narrowing of the T cell repertoire has pro-
found consequences for immune function, rendering the elderly
less responsive to immune stimulation and vaccination, as well as
predisposing them to cancer [76]. For example, a higher ratio of
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memory T cells and Treg lymphocytes versus naı̈ve T cells has
been observed in aged SJL/J mice, which are prone to
Hodgkin’s-like lymphoma [77]. The resulting “shrunken”, naı̈ve
T cell pool leads to an age-associated imbalance, which may con-
tribute to the occurrence of lymphoma in this mouse model. A
recent review by Nikolich-Zugich [78] summarizes the state-of-
the-art knowledge concerning aging-dependent changes in T cell
subsets and their relationship to infections with latent, persistent
pathogens. In addition to the accumulation of memory T cells
with age, selected changes in lymphocyte turnover have been re-
ported in animal and human aging. For example, there is a
marked reduction in turnover of memory CD8 in mice [79]. This
may be explained partially by the antiproliferative effect of in-
creased Bcl-2 expression and high levels of type-1 IFNs in aging.
Contraction of the naı̈ve T cell repertoire was shown to result in
impaired CD8 T cell responses in a mouse infection model [80].
In humans, there is evidence of significant contraction of the na-
ı̈ve human CD4 T cell repertoire in the seventh and eighth de-
cade of life [74]. By examining the uptake of deuterated glucose
into cells, Wallace et al. [72] showed that surprisingly, naı̈ve and
memory T cell and Treg subsets have similar turnover in young
and old people. The investigators also found that CD8 memory
cells have a much longer half-life than other T cell subsets in the
elderly. Furthermore, these persistent cells include large clonal
populations.
Impaired IL-2 production and proliferation
T cell proliferation and growth are induced by IL-2, but as T
cells age, they lose their capacity to produce and respond to
IL-2. When exposed to antigen, memory T cells will divide and
proliferate rapidly to elaborate more T cell clones but only
proliferate upon stimulation with IL-2. If insufficient concen-
trations of IL-2 are produced or if T cells cannot respond ef-
fectively to IL-2, T cell function is greatly impaired. Age-re-
lated impairments in the activation of transcription factors
AP-1 and NF-AT have been closely associated with decreased
expression of IL-2 by human T cells [81–83]. Additional to
the aberrant cytokine response, naı̈ve T cells in aged humans
and rodents display multiple defects in early signaling events
and impaired calcium influx compared with their younger co-
horts [84].
T cell migration
In RA, migration of T cells to the synovium is facilitated by a
number of chemokines, including MIP-1 and SDF-1. In addi-
tion to promoting angiogenesis and degradation of cartilage
matrix by stimulating release of matrix metalloprotease-13
from human chondrocytes [85], SDF-1 inhibits activation-in-
duced apoptosis of T cells [86]. MIP-1, present at elevated
concentrations in synovial fluid when compared with serum of
patients with RA, has been implicated in macrophage recruit-
ment to the rheumatoid synovium. Recent work from our lab-
oratory [87] indicates that expression of selected proinflamma-
tory chemokines and chemokine receptors is increased in aged
human and murine T cells. The enhanced proinflammatory T
cell chemotactic responses may play a role in the pathogenesis
of inflammatory diseases in aging, including cardiovascular
diseases and autoimmunity. Conversely, the decrease in T cell
CCR7 expression and function, in part related to the age-re-
lated decline in naı̈ve T cell populations, may explain the ob-
served defective T cell homing to secondary lymphoid organs
in aging.
Tregs and Th17 cells
Whether the number of CD4CD25hi Tregs changes during
aging is uncertain. Although most studies report no correla-
tion between circulating Treg numbers and aging, a select few
have demonstrated a positive association [88, 89]. It has been
suggested that aged Tregs inhibit CD8 cell cytotoxicity via re-
duced production of IFN and perforin. An increase in Treg
numbers or function may therefore provide a potential mecha-
nism for the impaired immune response seen in older adults.
Although the effect of aging on human Th17 cells remains
uncertain, studies in rats have revealed that protein expression
of IL-17 is elevated in coronary arteries of old animals com-
pared with those of young animals [90]. Moreover, elevated
concentrations of IL-17 and TNF- have been detected in the
serum and synovial fluid of patients with RA and osteoarthritis
compared with healthy controls [91].
Decline of Th1 and enhanced Th2 response
A number of studies suggest an imbalance between Th1 and
Th2 responses in aging. However, the nature of this imbalance
remains an issue of significant controversy. Some, but not all,
published data support the notion that human aging is associ-
ated with a decline of Th1 and enhancement of Th2 immune
responses [92–94]. In contrast, studies in mice have generally
provided evidence for enhanced Th1 and impaired Th2 im-
mune responses [95, 96]. Most recently, Uciechowski et al.
[97] reported a decreased Th2/Th1 ratio in old compared
with young individuals. These researchers also concluded that
zinc deficiency is common in the elderly and that moderate
zinc supplementation is linked to an increase in Th2 cells.
APOPTOSIS
Aging affects all three major signaling pathways of apoptosis in
T cells (recently reviewed by Gupta [98]). The effect of aging
on the lymphocyte CD95 (APO/Fas) apoptotic signaling path-
way was studied by Potestio et al. [99]. This group of research-
ers found increased CD95 expression in humans up to the age
of 75 years, followed by a decline in CD95 expression in CD4
but not CD8 T cells from the very old [99]. The increase in
CD95 expression may be, in part, secondary to the more acti-
vated state of old T cells and correlates to enhanced apoptosis
[99, 100]. The functional consequences of these T cell
changes are unclear, as CD8 cells from aged individuals have
increased perforin expression that would suggest that they may
also have preserved cytotoxic function [101]. Current data by
Gupta and Gollapudi [102] indicate that aging-associated defi-
ciencies in naı̈ve and central memory subsets of CD4 and
CD8 T cells may be linked to their increased sensitivity to
CD95-mediated apoptosis.
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T cell immune replicative senescence
T lymphocytes, like all human somatic cells, have a finite, pro-
liferative lifespan that is determined by telomere length. Age-
dependent decreases in telomere length have been reported
in B cells and T cells [103–107]. At birth, virtually all human
T cells express CD28, a costimulatory receptor that plays a piv-
otal role in their antigen-mediated activation, proliferation,
and survival [108]. It has been observed that human aging is
associated with a decreased ratio of CD28/CD28– T cells,
particularly in the CD8 subset. The loss of CD28 expression is
a marker of T cell replicative senescence [109–111], although
not all CD28– cells are senescent cells. In addition to loss of
CD28 gene expression and shortened telomeres, cultured CD
8 T cells that are subjected to repeated cycles of antigen-
driven proliferation also eventually display irreversible cell-cy-
cle arrest, apoptosis resistance, as well as reduced expression
of major stress proteins in response to heat shock (reviewed in
ref. [112]). Interestingly, compared with the “young-old” pop-
ulation (65 years and above), successfully aged nonagenarians
have a similar number of CD28 and CD28– cells but have
better preservation of CD8 T cell functions, including activa-
tion-induced cell death [113]. A recent review by Weng et al.
[108] highlights advances in our understanding of CD28– T
cells and their role in the age-associated decline of immune
function. Short telomeres in peripheral blood T lympho-
cytes as well as granulocytes have been reported in RA
[114], supporting the contention that RA is associated with
intrinsic abnormalities in telomere length and may repre-
sent a form of premature aging. Recent work using HIV-
specific CD8 cells has suggested that telomerase-based thera-
peutic approaches may prevent or at least retard replicative
senescence [115].
NKT cells
NKT cell cytotoxic function declines in humans and rodents
with age [116 –119], despite the fact that T cells acquire
many markers of NK cells (including CD16, CD56, CD57,
and CD94) over one’s lifetime. Thus, it was shown that T
cells from older human adults with these NK cell markers
are hyporesponsive to antigen stimulation [117]. These
changes may contribute to the age-dependent, increased
susceptibility to parasitic and viral infections [118, 119]. For
a detailed analysis of age-related changes in NKT cell func-
tion, the interested reviewer is referred to several recent
reviews by Panda et al. [120], Mocchegiani et al. [121, 122],
and Peralbo et al. [123].
B CELLS
Memory B lymphocytes express the surface marker CD27. Col-
onna-Romano et al. [124] observed that the percentage of
CD27 cells was slightly elevated in the elderly and that serum
concentrations of IgD correlate negatively with CD27 B cells.
Naı̈ve B cell (IgDCD27–) numbers, on the other hand, were
reduced significantly in the elderly. In contrast to this report,
Shi et al. [125] found that memory B cells decline with age,
whereas Chong et al. [126] reported that numbers of memory
B cells decrease, and those of naı̈ve B cells increase with age.
Although the overall number of B cells is relatively stable
across a human lifespan, there are clear changes in B cell gen-
eration and repertoire. In general, this results in a shift in the
antibody specificity away from foreign to autologous antigens.
Furthermore, there is an associated narrowing of the diversity
of the B cell antibody response resulting in the impaired abil-
ity of the aging immune system to generate high-affinity anti-
bodies, the appearance of mAb, and clonal B cell expansion.
Clinical consequences of these changes include impaired re-
sponses to infection, cancer cells, vaccination, and the poten-
tial for late-life B cell lymphomas. Using DNA samples from
peripheral blood, work by Gibson et al. [127] revealed that
the dramatic collapse of B cell repertoire diversity in the el-
derly correlated strongly with general health status and was a
marker of frailty. Recent reviews by Cancro et al. [128], Sie-
grist and Aspinall [129], and Caruso et al. [130] focus on ag-
ing-mediated changes in B cells and their responses to vaccina-
tion, respectively.
CONCLUSION
Understanding immune system changes in aging has impor-
tant implications as humans pursue longevity and at the same
time, aim to reduce the burden of disease that comes with ag-
ing. Recent advances in the field should allow researchers to
devise novel strategies to prevent and treat ailments that pref-
erentially afflict the elderly, such as infectious diseases and
cancer. The realization that old age is associated with a state
of low-grade inflammation that provides the background for
susceptibility to diverse diseases also presents a new avenue for
research into reversing these changes and to improve the out-
come of chronic inflammatory diseases in the elderly.
REFERENCES
1. Fagiolo, U., Cossarizza, A., Scala, E., Fanales-Belasio, E., Ortolani, C.,
Cozzi, E., Monti, D., Franceschi, C., Paganelli, R. (1993) Increased cyto-
kine production in mononuclear cells of healthy elderly people. Eur.
J. Immunol. 23, 2375–2378.
2. Franceschi, C. (2007) Inflammaging as a major characteristic of old peo-
ple: can it be prevented or cured? Nutr. Rev. 65, S173–S176.
3. Nathan, C. (2006) Neutrophils and immunity: challenges and opportu-
nities. Nat. Rev. Immunol. 6, 173–182.
4. Fortin, C. F., McDonald, P. P., Lesur, O., Fulop Jr., T. (2008) Aging and
neutrophils: there is still much to do. Rejuvenation Res. 11, 873–882.
5. Gomez, C. R., Nomellini, V., Faunce, D. E., Kovacs, E. J. (2008) Innate
immunity and aging. Exp. Gerontol. 43, 718–728.
6. Niwa, Y., Kasama, T., Miyachi, Y., Kanoh, T. (1989) Neutrophil che-
motaxis, phagocytosis and parameters of reactive oxygen species in
human aging: cross-sectional and longitudinal studies. Life Sci. 44,
1655–1664.
7. Wenisch, C., Patruta, S., Daxbock, F., Krause, R., Horl, W. (2000) Effect
of age on human neutrophil function. J. Leukoc. Biol. 67, 40–45.
8. Biasi, D., Carletto, A., Dell’Agnola, C., Caramaschi, P., Montesanti, F.,
Zavateri, G., Zeminian, S., Bellavite, P., Bambara, L. M. (1996) Neutro-
phil migration, oxidative metabolism, and adhesion in elderly and
young subjects. Inflammation 20, 673–681.
9. Esparza, B., Sanchez, H., Ruiz, M., Barranquero, M., Sabino, E., Merino,
F. (1996) Neutrophil function in elderly persons assessed by flow cytom-
etry. Immunol. Invest. 25, 185–190.
10. Fulop, T., Larbi, A., Douziech, N., Fortin, C., Guerard, K. P., Lesur, O.,
Khalil, A., Dupuis, G. (2004) Signal transduction and functional
changes in neutrophils with aging. Aging Cell 3, 217–226.
11. Tortorella, C., Polignano, A., Piazzolla, G., Serrone, M., Jirillo, E., An-
tonaci, S. (1996) Lipopolysaccharide-, granulocyte-monocyte colony
stimulating factor and pentoxifylline-mediated effects on formyl-methio-
1006 Journal of Leukocyte Biology Volume 87, June 2010 www.jleukbio.org
nyl-leucine-phenylalanine-stimulated neutrophil respiratory burst in the
elderly. Microbios 85, 189–198.
12. Tortorella, C., Simone, O., Piazzolla, G., Stella, I., Antonaci, S. (2007)
Age-related impairment of GM-CSF-induced signaling in neutrophils:
role of SHP-1 and SOCS proteins. Ageing Res. Rev. 6, 81–93.
13. Fulop Jr., T., Foris, G., Worum, I., Paragh, G., Leovey, A. (1985) Age
related variations of some polymorphonuclear leukocyte functions.
Mech. Ageing Dev. 29, 1–8.
14. Lord, J. M., Butcher, S., Killampali, V., Lascelles, D., Salmon, M. (2001)
Neutrophil aging and immunesenescence. Mech. Ageing Dev. 122, 1521–
1535.
15. Ogawa, K., Suzuki, K., Okutsu, M., Yamazaki, K., Shinkai, S. (2008) The
association of elevated reactive oxygen species levels from neutrophils
with low-grade inflammation in the elderly. Immun. Ageing 5, 13.
16. Alonso-Fernandez, P., Puerto, M., Mate, I., Ribera, J. M., de la Fuente,
M. (2008) Neutrophils of centenarians show function levels similar to
those of young adults. J. Am. Geriatr. Soc. 56, 2244–2251.
17. Brown-Borg, H. M., Rakoczy, S. G. (2000) Catalase expression in de-
layed and premature aging mouse models. Exp. Gerontol. 35, 199–212.
18. Nishio, N., Okawa, Y., Sakurai, H., Isobe, K. (2008) Neutrophil deple-
tion delays wound repair in aged mice. Age (Dordr.) 30, 11–19.
19. Van Leeuwen, M., Gijbels, M. J., Duijvestijn, A., Smook, M., van de Gaar,
M. J., Heeringa, P., de Winther, M. P., Tervaert, J. W. (2008) Accumula-
tion of myeloperoxidase-positive neutrophils in atherosclerotic lesions in
LDLR/ mice. Arterioscler. Thromb. Vasc. Biol. 28, 84–89.
20. Zernecke, A., Bot, I., Djalali-Talab, Y., Shagdarsuren, E., Bidzhekov, K.,
Meiler, S., Krohn, R., Schober, A., Sperandio, M., Soehnlein, O., Borne-
mann, J., Tacke, F., Biessen, E. A., Weber, C. (2008) Protective role of
CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils
in atherosclerosis. Circ. Res. 102, 209–217.
21. Martin, C., Burdon, P. C., Bridger, G., Gutierrez-Ramos, J. C., Williams,
T. J., Rankin, S. M. (2003) Chemokines acting via CXCR2 and CXCR4
control the release of neutrophils from the bone marrow and their re-
turn following senescence. Immunity 19, 583–593.
22. Sainz, J., Sata, M. (2008) Open sesame! CXCR4 blockade recruits neu-
trophils into the plaque. Circ. Res. 102, 154–156.
23. Weisel, K. C., Bautz, F., Seitz, G., Yildirim, S., Kanz, L., Mohle, R. (2009)
Modulation of CXC chemokine receptor expression and function in
human neutrophils during aging in vitro suggests a role in their clear-
ance from circulation. Mediators Inflamm. 2009, 790174.
24. Busse, P. J., Zhang, T. F., Srivastava, K., Schofield, B., Li, X. M. (2007)
Effect of aging on pulmonary inflammation, airway hyperresponsiveness
and T and B cell responses in antigen-sensitized and -challenged mice.
Clin. Exp. Allergy 37, 1392–1403.
25. Yagi, T., Sato, A., Hayakawa, H., Ide, K. (1997) Failure of aged rats to
accumulate eosinophils in allergic inflammation of the airway. J. Allergy
Clin. Immunol. 99, 38–47.
26. Mathur, S. K., Schwantes, E. A., Jarjour, N. N., Busse, W. W. (2008) Age-
related changes in eosinophil function in human subjects. Chest 133,
412–419.
27. Ohnmacht, C., Voehringer, D. (2009) Basophil effector function and
homeostasis during helminth infection. Blood 113, 2816–2825.
28. Marone, G., Giugliano, R., Lembo, G., Ayala, F. (1986) Human basophil
releasability. II. Changes in basophil releasability in patients with atopic
dermatitis. J. Invest. Dermatol. 87, 19–23.
29. Gurish, M. F. (2009) The expanding universe of the basophil. Blood 113,
2616.
30. Moore, M. L., Newcomb, D. C., Parekh, V. V., Van Kaer, L., Collins,
R. D., Zhou, W., Goleniewska, K., Chi, M. H., Mitchell, D., Boyce, J. A.,
Durbin, J. E., Sturkie, C., Peebles Jr., R. S. (2009) STAT1 negatively reg-
ulates lung basophil IL-4 expression induced by respiratory syncytial vi-
rus infection. J. Immunol. 183, 2016–2026.
31. Sokol, C. L., Barton, G. M., Farr, A. G., Medzhitov, R. (2008) A mecha-
nism for the initiation of allergen-induced T helper type 2 responses.
Nat. Immunol. 9, 310–318.
32. Dace, D. S., Apte, R. S. (2008) Effect of senescence on macrophage po-
larization and angiogenesis. Rejuvenation Res. 11, 177–185.
33. Stout, R. D., Suttles, J. (2005) Immunosenescence and macrophage
functional plasticity: dysregulation of macrophage function by age-asso-
ciated microenvironmental changes. Immunol. Rev. 205, 60–71.
34. Kelly, J., Ali Khan, A., Yin, J., Ferguson, T. A., Apte, R. S. (2007) Senes-
cence regulates macrophage activation and angiogenic fate at sites of
tissue injury in mice. J. Clin. Invest. 117, 3421–3426.
35. Van Duin, D., Shaw, A. C. (2007) Toll-like receptors in older adults.
J. Am. Geriatr. Soc. 55, 1438–1444.
36. Sebastián, C., Herrero, C., Serra, M., Lloberas, J., Blasco, M. A., Celada,
A. (2009) Telomere shortening and oxidative stress in aged macro-
phages results in impaired STAT5a phosphorylation. J. Immunol. 183,
2356–2364.
37. Iancu, E. M., Speiser, D. E., Rufer, N. (2008) Assessing aging of individ-
ual T lymphocytes: mission impossible? Mech. Ageing Dev. 129, 67–78.
38. Ginaldi, L., De Martinis, M. (2009) Phenotypic and functional changes
of circulating monocytes in elderly. In Handbook on Immunosenescence (T.
Fulop, C. Franceschi, K. Hirokawa, G. Pawelec, eds.), New York, NY,
USA, Springer Science, 511–528.
39. Takeuchi, S., Furue, M., Takeuchi, S., Furue, M. (2007) Dendritic cells:
ontogeny. Allergol. Int. 56, 215–223.
40. Steinman, R. M., Banchereau, J. (2007) Taking dendritic cells into med-
icine. Nature 449, 419–426.
41. Banchereau, J., Steinman, R. M. (1998) Dendritic cells and the control
of immunity. Nature 392, 245–252.
42. Ueno, H., Klechevsky, E., Morita, R., Aspord, C., Cao, T., Matsui, T., Di
Pucchio, T., Connolly, J., Fay, J. W., Pascual, V., Palucka, A. K., Banche-
reau, J. (2007) Dendritic cell subsets in health and disease. Immunol.
Rev. 219, 118–142.
43. Klechevsky, E., Liu, M., Morita, R., Banchereau, R., Thompson-Snipes,
L., Palucka, A. K., Ueno, H., Banchereau, J. (2009) Understanding hu-
man myeloid dendritic cell subsets for the rational design of novel vac-
cines. Hum. Immunol. 70, 281–288.
44. Ueno, H., Klechevsky, E., Morita, R., Aspord, C., Cao, T., Matsui, T., Di
Pucchio, T., Connolly, J., Fay, J. W., Pascual, V., Banchereau, J. (2007)
Dendritic cell subsets in health and disease. Immunol. Rev. 219, 118–142.
45. Agrawal, A., Agrawal, S., Tay, J., Gupta, S. (2008) Biology of dendritic
cells in aging. J. Clin. Immunol. 28, 14–20.
46. Shurin, M. R., Shurin, G. V., Chatta, G. S. (2007) Aging and the den-
dritic cell system: implications for cancer. Crit. Rev. Oncol. Hematol. 64,
90–105.
47. Jing, Y., Shaheen, E., Drake, R. R., Chen, N., Gravenstein, S., Deng, Y.
(2009) Aging is associated with a numerical and functional decline in
plasmacytoid dendritic cells, whereas myeloid dendritic cells are rela-
tively unaltered in human peripheral blood. Hum. Immunol. 70, 777–
784.
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